In patients with asthma, macrolides vs. placebo or standard care reduce severe exacerbations and improve symptom control at ≤48 wk

By afschroeder • July 7, 2026

Hoo GWS; ACP Journal Club Editorial Team at McMaster University. In patients with asthma, macrolides vs. placebo or standard care reduce severe exacerbations and improve symptom control at ≤48 wk. Ann Intern Med. 2026 Jul 7. doi: 10.7326/ANNALS-26-02405-JC. Epub ahead of print. PMID: 42407070.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine, Veterans Administration

Jackhammer Esophagus Presenting as Chest Discomfort and Dyspnea in a Patient With Undifferentiated Inflammatory Arthritis and a Positive Scl-70 Antibody Test

Perini Villanueva G, Kokaly A, Sunku N, Chung CW. Jackhammer Esophagus Presenting as Chest Discomfort and Dyspnea in a Patient With Undifferentiated Inflammatory Arthritis and[...]

Association Between Colchicine Use and Clinical Outcomes Post Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials

Jaiswal V, Hanif M, Raja HAA, Khadka S, Deb N, Mashkoor Y, Ahmed A, Rajak K, Jaiswal AK, Gupta M, Hirji S, Fonarow GC, Qamar[...]

A Multicenter Randomized Controlled Trial of a Digital Health Intervention for Medication Optimization in Heart Failure: The ENGAGE-HF Trial Outcomes

Dorsch MP, Gilotra NA, Spaulding EM, Martin SS, Zhao H, Wilson GA, Poddar M, Verma A, Schmiedmayer P, Kraft P, Rodriguez F, Azizi Z, Hwang[...]